Skip to main content
Premium Trial:

Request an Annual Quote

Swiss-Prot and Trembl, RLX Blast Cluster Solution

Premium

The Swiss-Prot team at the European Bioinformatics Institute has released the first draft of SP-ML, its new XML format for the Swiss-Prot and Trembl databases. The format is expected to aid developers who currently must create their own parsers and conversion tools.

Further information, examples, and downloads are available at www.ebi.ac.uk/swissprot/SP-ML.

 

Blade server vendor RLX Technologies of The Woodlands, Texas, has released RLX Blast Cluster Solution, a platform that uses Platform Computing’s Clusterware to improve Blast processing in compute clusters. According to RLX, “plugging-in five, ten, or 24 RLX Blast ServerBlades into the RLX chassis creates a bioinformatics compute cluster,” which is then managed with RLX Control Tower 2 and Platform’s Clusterware software. Each RLX Blast Cluster Solution bundle consists of one RLX System 300ex, one RLX Control Tower Blade 2, five RLX Blast Cluster ServerBlades, and five RLX Control Tower 2 user licenses, priced up to $16,900. The RLX Blast Cluster ServerBlade is also individually priced up to $2,750.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.